Calithera Biosciences Inc (CALA)
Calithera Biosciences, Inc. is a common stock listing on OTC Markets under the symbol CALA. The company is operating under a plan of liquidation that was approved in January 2023. Before that process, Calithera focused on clinical-stage precision oncology biopharmaceutical development. Incorporated in 2010, the company is headquartered in South San Francisco, California. The listing reflects the issuer’s common equity and its current liquidation status rather than an ongoing operating biotechnology business.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap |
|---|---|---|---|---|---|---|---|
|
OTC-CALA
|
Not available
|
Not available
|
Not available
|
Fair
|
0.0%
|
November 17, 2026
|
1.461 K
|
